Investment Summary

GIMV and EQT Life Sciences Invest In Onwards

On April 19, 2016, private equity firm GIMV and growth capital firm EQT Life Sciences invested in life science company Onwards

Investment Highlights
  • This is GIMV’s 14th and EQT Life Sciences’ 4th transaction in the Life Science sector.
  • This is GIMV’s 28th and EQT Life Sciences’ 6th transaction in the Netherlands.

Investment Summary

Date 2016-04-19
Target Onwards
Sector Life Science
Investor(s) GIMV
EQT Life Sciences
Deal Type Venture

Target

Onwards

Eindhoven, Netherlands
Onwards is a developer of implantable neuro stimulator for patients with incomplete spinal cord injury. Onwards was founded in 2014 and is based in Eindhoven, Netherlands.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 2

Investor

GIMV

Antwerp, Belgium

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1980
PE ASSETS 2.0B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

GIMV is a Belgium based public investment company focused on private equity and venture capital investments in tech-based businesses. GIMV's private equity practice operates through its Corporate Investment unit and targets management buyouts, buy-ins, and growth capital financings of companies with annual sales between EUR15 and EUR150 million. For buyout opportunities GIMV generally takes a majority stake in businesses and for growth capital needs, GIMV takes a minority position. GIMV does not invest in publicly held companies or turnaround situations. GIMV's geographic focus is within Belgium, Netherlands, Germany, and France. GIMV also invests in Russia through Eagle Capital Partners, a partnership with KBC Private Equity. GIMV was formed in 1980 and is headquartered in Antwerp with additional offices in The Hague, Frankfurt, Munich, and Paris.


DEAL STATS #
Overall 101 of 170
Sector: Life Science M&A 14 of 24
Type: Venture M&A Deals 29 of 39
Country: Netherlands M&A 28 of 42
Year: 2016 M&A 6 of 11
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-04-18 GreenPeak Technologies B.V.

Utrecht, Netherlands

GreenPeak Technologies B.V. is a provider of ultra low power wireless transceiver chips and modules with energy harvesting ready interfaces, using innovative low power mesh protocol, compliant to industry standards (IEEE 802.15.4 and ZigBee).

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-04-28 Joolz

Amsterdam, Netherlands

Joolz is a designer and manufacturer of pushchairs. Joolz is based in Amsterdam, Netherlands.

Buy -
Investor

EQT Life Sciences


Category Growth Capital Firm
Founded 1987
PE ASSETS 3.5B EUR
Size Large
Type Sector Focused
DESCRIPTION

EQT Life Sciences (formerly Life Science Partners) is a private investment firm focused on growth and venture capital financing for life sciences and healthcare companies. The Firm targets early to mid?stage companies in sectors such as therapeutics, medical devices, diagnostics, healthtech, and biotech. EQT Life Sciences was formed in 1986 and is headquartered in Amsterdam, the Netherlands.


DEAL STATS #
Overall 10 of 47
Sector: Life Science M&A 4 of 30
Type: Venture M&A Deals 8 of 39
Country: Netherlands M&A 6 of 10
Year: 2016 M&A 3 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-03-14 eTheRNA

Niel, Belgium

eTheRNA is developing its proprietary TriMix mRNA-based immunotherapies for melanoma, breast cancer and infectious diseases. eTheRNA was founded in 2013 and is based in Niel, Belgium.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-05-17 Nouscom

Basel, Switzerland

Nouscom is developing next-generation neo-epitope vaccines and oncolytic viruses. Nouscom was founded in 2015 and is based in Basel, Switzerland.

Buy -